Gut Microbiota Changes in Experimental Autoimmune Encephalomyelitis and Cuprizone Mice Models

Area of Science:

• Neuroimmunology
• Microbiome Research

Background:

• Multiple sclerosis (MS) is a CNS neurodegenerative disease involving immune-mediated demyelination.
• Alterations in gut microbiota are increasingly linked to MS, but the direct connection to demyelination remains unclear.

Purpose of the Study:

• To characterize microbial dysbiosis in murine models of demyelination.
• To correlate gut microbiota changes with disease progression in these models.
• To assess the models' suitability for predicting microbial changes in MS patients.

Main Methods:

• Induction of experimental autoimmune encephalomyelitis (EAE) and cuprizone (CPZ) models in C57BL/6 mice.
• Monitoring disease progression (4 weeks for EAE, 9 weeks for CPZ).
• Fecal sample collection, motor skill evaluation (EAE scale), and demyelination assessment (MRI).

Main Results:

• Both EAE and CPZ models exhibited significant microbial alterations correlating with disease progression.
• These observed microbial changes largely mirrored the dysbiosis characteristics found in MS patients.
• Animal models provide a controlled environment to study host-microbiota interactions in demyelination.

Conclusions:

• Murine demyelination models demonstrate significant gut microbiota changes that correlate with disease progression.
• These models effectively replicate key microbial dysbiosis features observed in multiple sclerosis patients.
• Understanding these host-microbiota interactions in controlled settings can inform future therapeutic strategies for MS.